z-logo
open-access-imgOpen Access
A Review of Nelarabine in the Treatment of T-cell Lymphoblastic Leukemia/Lymphoma
Author(s) -
Francisco J. HernandezIlizaliturri,
Myron S. Czuczman
Publication year - 2009
Publication title -
clinical medicine therapeutics
Language(s) - English
Resource type - Journals
ISSN - 1179-1713
DOI - 10.4137/cmt.s1954
Subject(s) - medicine , lymphoblastic lymphoma , chemotherapy , lymphoma , lymphoblastic leukemia , refractory (planetary science) , clofarabine , oncology , salvage therapy , leukemia , t cell , cytarabine , immunology , immune system , physics , astrobiology
Patients with relapsed/refractory T-cell acute lymphocytic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL) have a dismal prognosis. Prior to the development of novel purine analogs, salv...

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom